Delivery Order SPE2DB20D1100-SPE2DB25FE1QW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price delivery order is valued at $119,604.20 and is scheduled for completion by October 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and operates as a child...
- The Defense Logistics Agency (DLA) awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance completion targeted for September 9, 2025. This non-competitive delivery order employs firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price delivery order, valued at $5,980.21, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order carries an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $119,604.20 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with completion targeted for October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with a contract ceiling value of $478,416.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by October 6, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $35,881.26 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with an ultimate completion date of October 20, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $239,208.40, represents a competitively awarded, non-set-aside contract with a completion deadline of October 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $11,960.42, represents a non-competitive, non-set-aside procurement and is scheduled for completion by August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $17,940.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product on August 25, 2025, with an ultimate completion date of September 16, 2025. This is a non-set-aside competitive award with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1QWDelivery Order
The Defense Logistics Agency (DLA) awarded a $107,643.78 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with an ultimate completion date of October 21, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's comprehensive IDC vehicle enables supply of a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This specific delivery order for the specialty medication Darzalex Faspro reflects the company's role in supporting military healthcare programs with brand-name pharmaceutical products essential to ongoing treatment protocols.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $107.6k | 9/29/25 |